Literature DB >> 13652024

Clinical experience with DBI (phenformin) in the management of diabetes.

J B McKENDRY, K KUWAYTI, P P RADO.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13652024      PMCID： PMC1831029     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Oral hypoglycemic agents in the management of diabete.

Authors:  A MARBLE
Journal:  Med Clin North Am       Date:  1958-09       Impact factor: 5.456

2.  Pharmacological studies of a new oral hypoglycemic drug.

Authors:  G UNGAR; L FREEDMAN; S L SHAPIRO
Journal:  Proc Soc Exp Biol Med       Date:  1957-05

3.  Historical review of oral substitutes for insulin.

Authors:  M G GOLDNER
Journal:  Diabetes       Date:  1957 May-Jun       Impact factor: 9.461

4.  Effects on blood sugar of a new potent hypoglycemic compound.

Authors:  R L NIELSEN; H E SWANSON; D C TANNER; R H WILLIAMS; M O'CONNELL
Journal:  AMA Arch Intern Med       Date:  1958-02

5.  Experience with tolbutamide (orinase in the management of 100 cases of diabetes.

Authors:  J B McKENDRY; K KUWAYTI; L A SAGLE
Journal:  Can Med Assoc J       Date:  1957-09-01       Impact factor: 8.262
  5 in total
  5 in total

1.  Metformin: historical overview.

Authors:  Clifford J Bailey
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET.

Authors:  Avner Schlessinger; Ethan Geier; Hao Fan; John J Irwin; Brian K Shoichet; Kathleen M Giacomini; Andrej Sali
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-01       Impact factor: 11.205

3.  Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.

Authors:  Zongjian Zhu; Weiqin Jiang; Matthew D Thompson; Dimas Echeverria; John N McGinley; Henry J Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-24

4.  Design, synthesis and biological activity evaluation of a new class of 2,4-thiazolidinedione compounds as insulin enhancers.

Authors:  Zou Huiying; Chen Guangying; Zhou Shiyang
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 5.  Cellular and Molecular Mechanisms of Metformin Action.

Authors:  Traci E LaMoia; Gerald I Shulman
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.